Navigation Links
New dwarfism mutation identified in dogs
Date:9/26/2013

Professor Hannes Lohi's research group at the University of Helsinki and Folkhlsan Research Center has identified a mutation in ITGA10 gene, causing chondrodysplasia in two dog breeds, the Norwegian Elkhound and the Karelian Bear Dog. The research revealed a new chondrodysplasia gene in dogs, and a candidate gene for human chondrodysplasias. The finding has implications on bone biology as well as canine health. A genetic test can now be used to identify mutation carriers in the two affected dog breeds. The study was published on the scientific journal PLOS ONE on 25 September 2013.

The ITGA10 mutation causes autosomal recessive disproportionate short-stature dwarfism of varying severity. The appearance of affected dogs is characterized considerably shorter limbs than normal dogs, and other skeletal abnormalities may follow, including bowed forearms, abnormal digits, and malformed femoral heads.

The ITGA10 gene codes for an integrin subunit that assembles into a cartilage-specific collagen receptor, found in the growth plates of long bones. The receptor is important for the process of endochondral ossification, in which the cartilage cells first proliferate, and are then replaced by bone tissue. Accordingly, several abnormalities have been found in the growth plates of affected dogs both in radiographic and histological examinations.

Collagen-receptor mutation causes growth disturbances

The causative mutation was mapped to a specific region on canine chromosome 17 by comparing the genomes of affected and healthy dogs. Further analysis of this chromosomal region revealed a single nucleotide change in the ITGA10 gene, which disrupts the gene by introducing signal that prematurely ends the production of the encoded integrin subunit. "Because of the premature stop codon, the full length integrin subunit is never made, and consequently, there are no functional receptors in the affected dogs' growth plates. This causes the growth disturbances", explains Professor Lohi, and continues: "Several collagen mutations have been previously found in different growth disorders but this is only the second collagen receptor that has been linked to inherited chondrodysplasia. Our canine disease model offers new possibilities to study growth plate biology".

The results of the study may have implications to human medicine as well. "Humans also suffer from different types of inherited chondrodysplasia, and the ITGA10 gene could represent a good candidate gene for some of these disorders, which still have an unknown genetic cause", tells Kaisa Kystil, the first author of the paper. "We have already begun screening human patients for mutations in the gene", she adds.

A gene test recognizes mutation carrier dogs

The studied canine chondrodysplasia was initially described in Norwegian Elkhounds in the 1980's, and the current study identifies a corresponding problem in Karelian Bear Dogs. "Both breeds have now benefited from a genetic test that is available for dog owners", tells Professor Lohi. "The test is used to recognize mutation carriers, and the long-term aim is to eradicate the mutation and the disease from the dog breeds", he concludes.


'/>"/>

Contact: Hannes Lohi
hannes.lohi@helsinki.fi
358-919-25085
University of Helsinki
Source:Eurekalert

Related biology news :

1. Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size
2. Study confirms that rare mutations increase risk of late-onset Alzheimers disease
3. Boy interrupted: Y-chromosome mutations reveal precariousness of male development
4. Genetic mutations linked to Parkinsons disease
5. Gene mutations caused by a fathers lifestyle can be inherited by multiple generations
6. Powerful gene-editing tool appears to cause off-target mutations in human cells
7. Rare mitochondrial mutations -- maybe not so rare?
8. How disease mutations affect the Parkin protein
9. Family studies suggest rare genetic mutations team up to cause schizophrenia
10. PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
11. Non-inherited mutations account for many heart defects, Yale researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... Calif. , March 28, 2017 ... of international life sciences corporation Anpac Bio-Medical ... set a new, international record, processing and reporting ... "Cancer Differentiation Analysis" (CDA) liquid biopsy ... World Nobel Prize Laureate Summit publications, Anpac Bio,s ...
(Date:3/28/2017)... ... 2017 , ... LabKey and collaborator Just Biotherapeutics, Inc. (Just) ... LabKey Biologics . Built in collaboration with Just and designed with input from ... research teams tools for biological entity registration, assay data integration, and workflow management ...
(Date:3/28/2017)... , March 28, 2017 ... volatile and unpredictable sector due to the scientifically ... served include medical, agricultural, environmental, and industrial. In today,s ... stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. ... Ocular Therapeutix Inc. (NASDAQ: OCUL ). ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
Breaking Biology Technology: